Regulation of miRNAs affects radiobiological response of lung cancer stem cells

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Xu, Yan Mei ^a   Liao, Xing Yun ^a   Chen, Xie Wan ^a   Li, De Zhi ^a   Sun, Jian Guo ^a   Liao, Rong Xia ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 107; MICRORNA 145; MICRORNA 155; MICRORNA 200B; MICRORNA 210; MICRORNA 31; MICRORNA 34A;

CANCER GROWTH; CANCER INFILTRATION; CANCER RADIOTHERAPY; CANCER STEM CELL; CANCER THERAPY; CELL FUNCTION; CELL POPULATION; CELLULAR DISTRIBUTION; DNA DAMAGE; DNA REPAIR; GENE CONTROL; GENE SILENCING; HUMAN; LUNG CANCER; NONHUMAN; RADIOLOGICAL PARAMETERS; RADIOSENSITIVITY; RECOMBINATION REPAIR; REOXYGENATION; REVIEW; BIOSYNTHESIS; CARCINOGENESIS; GENE EXPRESSION REGULATION; GENETICS; LUNG NEOPLASMS; METABOLISM; PATHOLOGY; RADIATION DOSE; RADIATION RESPONSE;

CARCINOGENESIS; DNA DAMAGE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MICRORNAS; NEOPLASTIC STEM CELLS; RADIATION TOLERANCE;

EID: 84925307946     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/851841     Document Type: Review

References (72)

1. A. Jemal, F. Bray, M. M. Center, J. Ferlay, E. Ward, and D. Forman, "Global cancer statistics," CA Cancer Journal for Clinicians, vol. 61, no. 2, pp. 69-90, 2011.
2. D. S. Ettinger, W. Akerley, H. Borghaei et al., "Non-small cell lung cancer: clinical practice guidelines in oncology," Journal of the National Comprehensive Cancer Network, vol. 10, no. 10, pp. 1236-1271, 2012.
3. A.-R. Jazieh, H. Bamefleh, A. Demirkazik et al., "Modification and implementation of NCCN guidelines on non-small cell lung cancer in the Middle East and North Africa region," Journal of the National Comprehensive Cancer Network, vol. 8, supplement 3, pp. S16-S21, 2010.
4. A. van Baardwijk, W. A. Tomé, W. van Elmpt et al., "Is highdose stereotactic body radiotherapy (SBRT) for stage I nonsmall cell lung cancer (NSCLC) overkill? A systematic review," Radiotherapy and Oncology, vol. 105, no. 2, pp. 145-149, 2012.
5. S. Senthi, C. J. A. Haasbeek, B. J. Slotman, and S. Senan, "Outcomes of stereotactic ablative radiotherapy for central lung tumours: a systematic review," Radiotherapy and Oncology, vol. 106, no. 3, pp. 276-282, 2013.
6. S. Tyldesley, C. Boyd, K. Schulze, H. Walker, and W. J. Mackillop, "Estimating the need for radiotherapy for lung cancer: an evidence-based, epidemiologic approach," International Journal of Radiation Oncology Biology Physics, vol. 49, no. 4, pp. 973-985, 2001.
7. B. Dessard-Diana, D. Manoux, C. Diana, M. Housset, and F. Baillet, "Discussion on the role of radiotherapy in non-small cell lung cancer apropos of 137 non-metastatic cases," Cancer Radiothérapie, vol. 1, no. 2, pp. 154-158, 1997.
8. S.-H. Chiou, C.-L. Kao, Y.-W. Chen et al., "Identification of CD133-positive radioresistant cells in atypical teratoid/rhabdoid tumor," PLoS ONE, vol. 3, no. 5, Article IDe2090, 2008.
9. S. Bao, Q. Wu, R. E. McLendon et al., "Glioma stem cells promote radioresistance by preferential activation of the DNA damage response," Nature, vol. 444, no. 7120, pp. 756-760, 2006.
10. F. Pajonk, E. Vlashi, and W. H. McBride, "Radiation resistance of cancer stem cells: the 4 R's of radiobiology revisited," Stem Cells, vol. 28, no. 4, pp. 639-648, 2010.
11. T. Lapidot, C. Sirard, J. Vormoor et al., "A cell initiating human acute myeloid leukaemia after transplantation into SCID mice," Nature, vol. 367, no. 6464, pp. 645-648, 1994.
12. Á. Fábián, G. Vereb, and J. Szöllo{double acute}si, "The hitchhikers guide to cancer stem cell theory: markers, pathways and therapy," Cytometry Part A, vol. 83, no. 1, pp. 62-71, 2013.
13. Y. Shi, X. Fu, Y. Hua, Y. Han, Y. Lu, and J. Wang, "The side population in human lung cancer cell line NCI-H460 is enriched in stem-like cancer cells," PLoS ONE, vol. 7, no. 3, Article ID e33358, 2012.
14. M. M. Ho, A. V. Ng, S. Lam, and J. Y. Hung, "Side population in human lung cancer cell lines and tumors is enriched with stemlike cancer cells," Cancer Research, vol. 67, no. 10, pp. 4827-4833, 2007.
15. S. Singh, N. Bora-Singhal, J. Kroeger, H. Laklai, and S. P. Chellappan, "βarrestin-1 and Mcl-1 modulate self-renewal growth of cancer stem-like side-population cells in non-small cell lung cancer," PLoS ONE, vol. 8, no. 2, Article ID e55982, 2013.
16. B. Cao, J. Jia, L. Ma et al., "Recombinant human endostatin could eliminate the pro-angiogenesis priority of SP cells sorted fromnon-small cell lung cancer cells," Clinical and Translational Oncology, vol. 14, no. 8, pp. 575-585, 2012.
17. C. F. Bender Kim, E. L. Jackson, A. E. Woolfenden et al., "Identification of bronchioalveolar stem cells in normal lung and lung cancer," Cell, vol. 121, no. 6, pp. 823-835, 2005.
18. A. Eramo, F. Lotti, G. Sette et al., "Identification and expansion of the tumorigenic lung cancer stem cell population," Cell Death and Differentiation, vol. 15, no. 3, pp. 504-514, 2008.
19. P. Wang, Z. Suo, M. Wang et al., "In vitro and in vivo properties of CD133 expressing cells from human lung cancer cell lines," Experimental Hematology & Oncology, vol. 2, no. 1, article 16, 2013.
20. - subpopulations of A549 and H446 cells contain cancer-initiating cells," Cancer Science, vol. 100, no. 6, pp. 1040-1046, 2009.
21. + human lung adenocarcinoma initiating cells from A549," Molecules and Cells, vol. 33, no. 3, pp. 277-283, 2012.
22. E. L.-H. Leung, R. R. Fiscus, J.W. Tung et al., "Non-small cell lung cancer cells expressing CD44 are enriched for stem celllike properties," PLoSONE, vol. 5, no. 11, Article IDe14062, 2010.
23. K. Okudela, T. Woo, H. Mitsui, M. Tajiri, M. Masuda, and K. Ohashi, "Expression of the potential cancer stem cell markers, CD133, CD44, ALDH1, and β-catenin, in primary lung adenocarcinoma-their prognostic significance," Pathology International, vol. 62, no. 12, pp. 792-801, 2012.
24. X. Li, L. Wan, J. Geng, C.-L. Wu, and X. Bai, "Aldehyde dehydrogenase 1A1 possesses stem-like properties and predicts lung cancer patient outcome," Journal of Thoracic Oncology, vol. 7, no. 8, pp. 1235-1245, 2012.
25. W. C. Zhang, N. Shyh-Chang, H. Yang et al., "Glycine decarboxylase activity drives non-small cell lung cancer tumorinitiating cells and tumorigenesis," Cell, vol. 148, no. 1-2, pp. 259-272, 2012.
26. F. Karimi-Busheri, V. Zadorozhny, T. Li, H. Lin, D. L. Shawler, and H. Fakhrai, "Pivotal role of CD38 biomarker in combination with CD24, EpCAM, and ALDHfor identification of H460 derived lung cancer stem cells," Journal of Stem Cells, vol. 6, no. 1, pp. 9-20, 2011.
27. hi cells drives tumor propagation in NSCLC and requires Notch3 for self-renewal," Cancer Cell, vol. 24, no. 1, pp. 59-74, 2013.
28. Z. Xiao, Q. Jiang, J. Willette-Brown et al., "The pivotal role of IKKα in the development of spontaneous lung squamous cell carcinomas," Cancer Cell, vol. 23, no. 4, pp. 527-540, 2013.
29. G.-Y. Chiou, J.-Y. Cherng, H.-S. Hsu et al., "Cationic polyurethanes-short branch PEI-mediated delivery of Mir145 inhibited epithelial-mesenchymal transdifferentiation and cancer stem-like properties and in lung adenocarcinoma," Journal of Controlled Release, vol. 159, no. 2, pp. 240-250, 2012.
30. S. Zhang, Y. Wu, D. Feng et al., "miR-145 inhibits lung adenocarcinoma stem cells proliferation by targeting OCT4 gene," Chinese Journal of Lung Cancer, vol. 14, no. 4, pp. 317-322, 2011.
31. L. Song, C. Lin, Z. Wu et al., "MiR-18a impairs DNA damage response through downregulation of Ataxia telangiectasia mutated (ATM) kinase," PLoS ONE, vol. 6, no. 9, Article ID e25454, 2011.
32. K. M. Lee, E. J. Choi, and I. A. Kim, "MicroRNA-7 increases radiosensitivity of human cancer cells with activated EGFRassociated signaling," Radiotherapy and Oncology, vol. 101, no. 1, pp. 171-176, 2011.
33. S. Chen, H. Wang, W. L. Ng, W. J. Curran, and Y. Wang, "Radiosensitizing effects of ectopic miR-101 on non-small-cell lung cancer cells depend on the endogenous miR-101 level," International Journal of Radiation Oncology Biology Physics, vol. 81, no. 5, pp. 1524-1529, 2011.
34. D. Yan, W. L. Ng, X. Zhang et al., "Targeting DNA-PKcs and ATM with miR-101 sensitizes tumors to radiation," PLoS ONE, vol. 5, no. 7, Article ID e11397, 2010.
35. S. Grosso, J. Doyen, S. K. Parks et al., "MiR-210 promotes a hypoxic phenotype and increases radioresistance in human lung cancer cell lines," Cell Death and Disease, vol. 4, no. 3, article e544, 2013.
36. Q. Li, X. Li, Z. Guo et al., "MicroRNA-574-5p was pivotal for TLR9 signaling enhanced tumor progression via downregulating checkpoint suppressor 1 in human lung cancer," PLoS ONE, vol. 7, no. 11, Article ID e48278, 2012.
37. H. Hu, S. Li, J. Liu, and B. Ni, "MicroRNA-193b modulates proliferation, migration, and invasion of non-small cell lung cancer cells," Acta Biochimica et Biophysica Sinica, vol. 44, no. 5, pp. 424-430, 2012.
38. X. Dang, A. Ma, L. Yang et al., "MicroRNA-26a regulates tumorigenic properties of EZH2 in human lung carcinoma cells," Cancer Genetics, vol. 205, no. 3, pp. 113-123, 2012.
39. A. Saito, H. I. Suzuki, M. Horie et al., "An integrated expression profiling reveals target genes of TGF-beta and TNF-alpha possibly mediated by microRNAs in lung cancer cells," PLoS ONE, vol. 8, no. 2, Article ID e56587, 2013.
40. M. Cao, M. Seike, C. Soeno et al., "MiR-23a regulates TGF- β-induced epithelial-mesenchymal transition by targeting Ecadherin in lung cancer cells," International Journal of Oncology, vol. 41, no. 3, pp. 869-875, 2012.
41. L. Zhi-Yong, Z. Guang-Ling, W. Mei-Mei, X. Ya-Nan, and C. He-Qin, "MicroRNA-663 targets TGFB1 and regulates lung cancer proliferation," Asian Pacific Journal of Cancer Prevention, vol. 12, no. 11, pp. 2819-2823, 2011.
42. I. A. Babar, J. Czochor, A. Steinmetz, J. B. Weidhaas, P. M. Glazer, and F. J. Slack, "Inhibition of hypoxia-induced miR-155 radiosensitizes hypoxic lung cancer cells," Cancer Biology and Therapy, vol. 12, no. 10, pp. 908-914, 2011.
43. J.-S. Oh, J.-J. Kim, J.-Y. Byun, and I.-A. Kim, "Lin28-let7 modulates radiosensitivity of human cancer cells with activation of K-Ras," International Journal of Radiation Oncology Biology Physics, vol. 76, no. 1, pp. 5-8, 2010.
44. S.-H. Jeong, H.-G. Wu, and W.-Y. Park, "LIN28B confers radioresistance through the posttranscriptional control of KRAS," Experimental and Molecular Medicine, vol. 41, no. 12, pp. 912-918, 2009.
45. H. Arora, R. Qureshi, S. Jin, A.-K. Park, and W.-Y. Park, "miR- 9 and let-7g enhance the sensitivity to ionizing radiation by suppression of NFκB1," Experimental and Molecular Medicine, vol. 43, no. 5, pp. 298-304, 2011.
46. H. Salim, N. S. Akbar, D. Zong et al., "MiRNA-214 modulates radiotherapy response of non-small cell lung cancer cells through regulation of p38MAPK, apoptosis and senescence," British Journal of Cancer, vol. 107, no. 8, pp. 1361-1373, 2012.
47. J. Balça-Silva, S. S. Neves, A. C. Gonçalves et al., "Effect of miR- 34b overexpression on the radiosensitivity of non-small cell lung cancer cell lines," Anticancer Research, vol. 32, no. 5, pp. 1603-1609, 2012.
48. J. Mihatsch, M. Toulany, P. M. Bareiss et al., "Selection of radioresistant tumor cells and presence of ALDH1 activity in vitro," Radiotherapy & Oncology, vol. 99, no. 3, pp. 300-306, 2011.
49. L. Lundholm, P. Hååg, D. Zong et al., "Resistance to DNAdamaging treatment in non-small cell lung cancer tumorinitiating cells involves reduced DNA-PK/ATM activation and diminished cell cycle arrest," Cell Death & Disease, vol. 4, article e478, 2013.
50. P. Xia, W.-F. Gou, J.-J. Wang et al., "Distinct radiosensitivity of lung carcinoma stem-like side population andmain population cells," Cancer Biotherapy and Radiopharmaceuticals, vol. 28, no. 6, pp. 471-478, 2013.
51. R. C. Friedman, K. K.-H. Farh, C. B. Burge, and D. P. Bartel, "Most mammalian mRNAs are conserved targets of microRNAs," Genome Research, vol. 19, no. 1, pp. 92-105, 2009.
52. P. Sartipy, B. Olsson, J. Hyllner, and J. Synnergren, "Regulation of 'stemness' and stem cell differentiation by microRNAs," IDrugs, vol. 12, no. 8, pp. 492-496, 2009.
53. S. Hua, X. Xiaotao, G. Renhua et al., "Reduced miR-31 and let- 7 maintain the balance between differentiation and quiescence in lung cancer stem-like side population cells," Biomedicine and Pharmacotherapy, vol. 66, no. 2, pp. 89-97, 2012.
54. L. Zhao, A. M. Bode, Y. Cao, and Z. Dong, "Regulatory mechanisms and clinical perspectives of miRNA in tumor radiosensitivity," Carcinogenesis, vol. 33, no. 11, pp. 2220-2227, 2012.
55. H. Willers, C. G. Azzoli, W. L. Santivasi, and F. Xia, "Basic mechanisms of therapeutic resistance to radiation and chemotherapy in lung cancer," Cancer Journal, vol. 19, no. 3, pp. 200-207, 2013.
56. L. Wu, J. G. Sun, R. Xu et al., "miR-18a enhancing radiosensitivity of A549 cells and its molecular mechanism," The Journal of Third Military Medical University, vol. 35, no. 9, pp. 870-873, 2013 (Chinese).
57. Y. Tang, J. Hou, G. Li et al., "ABCG2 regulates the pattern of self-renewing divisions in cisplatin-resistant non-small cell lung cancer cell lines," Oncology Reports, vol. 32, no. 5, pp. 2168-2174, 2014.
58. J. D. O'Flaherty, M. Barr, D. Fennell et al., "The cancer stemcell hypothesis: Its emerging role in lung cancer biology and its relevance for future therapy," Journal of Thoracic Oncology, vol. 7, no. 12, pp. 1880-1890, 2012.
59. + A549 cell fraction," Cell Death and Disease, vol. 4, no. 5, article e620, 2013.
60. Y.-L. Lou, F. Guo, F. Liuet al., "MiR-210 activates notchsignaling pathway in angiogenesis induced by cerebral ischemia," Molecular and Cellular Biochemistry, vol. 370, no. 1-2, pp. 45-51, 2012.
61. V. G. Da Ros, I. Gutierrez-Perez, D. Ferres-Marco, and M. Dominguez, "Dampening the signals transduced through hedgehog via microRNA miR-7 facilitates notch-induced tumourigenesis," PLoS Biology, vol. 11, no. 5, Article IDe1001554, 2013.
62. D. M. Vallejo, E. Caparros, and M. Dominguez, "Targeting Notch signalling by the conserved miR-8/200 microRNAfamily in development and cancer cells," The EMBOJournal, vol. 30, no. 4, pp. 756-769, 2011.
63. G. Song, Y. Zhang, and L. Wang, "MicroRNA-206 targets notch3, activates apoptosis, and inhibits tumor cell migration and focus formation," Journal of Biological Chemistry, vol. 284, no. 46, pp. 31921-31927, 2009.
64. H. Iida, M. Suzuki, R. Goitsuka, and H. Ueno, "Hypoxia induces CD133 expression in human lung cancer cells by up-regulation of OCT3/4 and SOX2," International Journal of Oncology, vol. 40, no. 1, pp. 71-79, 2012.
65. M. Diehn, R.W. Cho, N. A. Lobo et al., "Association of reactive oxygen species levels and radioresistance in cancer stem cells," Nature, vol. 458, no. 7239, pp. 780-783, 2009.
66. J. M. Brown, D. J. Carlson, and D. J. Brenner, "The tumor radiobiology of SRS and SBRT: are more than the 5 Rs involved?" International Journal of Radiation Oncology Biology Physics, vol. 88, no. 2, pp. 254-262, 2014.
67. B. Liu, H. Zhang, X. Duan et al., "Adenovirus-mediated wildtype p53 transfer radiosensitizes H1299 cells to subclinical-dose carbon-ion irradiation through the restoration of p53 function," Cancer Biotherapy and Radiopharmaceuticals, vol. 24, no. 1, pp. 57-65, 2009.
68. G. Bridge, R. Monteiro, S. Henderson et al., "The microRNA- 30 family targets DLL4 to modulate endothelial cell behavior during angiogenesis," Blood, vol. 120, no. 25, pp. 5063-5072, 2012.
69. V. Levina, A. Marrangoni, T. Wang et al., "Elimination of human lung cancer stem cells through targeting of the stem cell factorc-kit autocrine signaling loop," Cancer Research, vol. 70, no. 1, pp. 338-346, 2010.
70. Z. Zheng, W. L. Ng, X. Zhang et al., "RNAi-mediated targeting of noncoding and coding sequences in DNA repair gene messages efficiently radiosensitizes human tumor cells," Cancer Research, vol. 72, no. 5, pp. 1221-1228, 2012.
71. Q. Yao, A.-M. Zhang, H. Ma et al., "Novel molecular beacons to monitor microRNAs in non-small-cell lung cancer," Molecular and Cellular Probes, vol. 26, no. 5, pp. 182-187, 2012.
72. M. Baumann, M. Krause, and R. Hill, "Exploring the role of cancer stem cells in radioresistance," Nature Reviews Cancer, vol. 8, no. 7, pp. 545-554, 2008.